Compare DSU & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DSU | NAGE |
|---|---|---|
| Founded | N/A | 1999 |
| Country | United States | United States |
| Employees | N/A | 117 |
| Industry | Finance Companies | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 622.4M | 386.0M |
| IPO Year | 1998 | N/A |
| Metric | DSU | NAGE |
|---|---|---|
| Price | $9.69 | $4.88 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 264.0K | ★ 1.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $20.75 |
| Revenue Next Year | N/A | $19.96 |
| P/E Ratio | ★ N/A | $21.29 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.72 | $4.72 |
| 52 Week High | $10.66 | $14.66 |
| Indicator | DSU | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 34.12 | 40.82 |
| Support Level | N/A | $4.73 |
| Resistance Level | $10.61 | $5.32 |
| Average True Range (ATR) | 0.09 | 0.27 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 24.29 | 16.90 |
Blackrock Debt Strategies Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide current income by investing in a diversified portfolio of U.S. companies' debt instruments including corporate loans. The fund's secondary investment objective is to provide capital appreciation.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.